METTL1 and neoplasm: Co‐expression of myr‐AKT1 and N‐RasV12 resulted in obvious liver enlargement and tumour burden within 4 weeks after injection in Mettl1‐KI group, resulting in significantly upregulation of liver weight to body weight ratio (Figure 7F, G).